US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 11.350
  • -0.120-1.05%
Close Dec 13 16:00 ET
478.96MMarket Cap-3.76P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

UroGen Pharma Ltd Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
24.20M
25.20M
+999.71K
Beat Est.
+16.08%
+20.87%
+4.13%
EPS
-0.81
-0.55
+0.26
Beat Est.
-19.86%
+19.12%
+32.51%
Analyst Rating
Strong Buy

Nov 30, 2024

UroGen Pharma Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 21.600M --
-- 2024/Q4 -- / 26.133M --
Nov 6, 2024 2024/Q3 25.204M / 24.204M --
Aug 13, 2024 2024/Q2 21.848M / 23.963M --
May 13, 2024 2024/Q1 18.781M / 21.391M --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 21.600M--
--2024/Q4-- / 26.133M--
Nov 6, 20242024/Q325.204M / 24.204M--
Aug 13, 20242024/Q221.848M / 23.963M--
May 13, 20242024/Q118.781M / 21.391M--

Unlock Free Earnings Estimates

UroGen Pharma Ltd Earnings Reports

  • UroGen Pharma Ltd | 10-Q: Q3 2024 Earnings Report

    Nov 6 21:07

  • UroGen Pharma Ltd | 8-K: UroGen Pharma Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

    Nov 6 21:07

  • UroGen Pharma Ltd | 10-Q: Q2 2024 Earnings Report

    Aug 13 20:07

  • UroGen Pharma Ltd | 8-K: UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights

    Aug 13 20:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data